Abstract:Purpose: Candida tropicalis (C. tropicalis) has emerged as an important fungal pathogen due to its increasing resistance to conventional antifungal agents, especially fluconazole (FLC). Pseudolaric acid B (PAB), a herbal-originated diterpene acid from Pseudolarix kaempferi Gordon, has been reported to possess inhibitory activity against fungus. The present study aims to investigate the antifungal effect of PAB alone and in combination with FLC on planktonic and biofilm cells of C. tropicalis.Methods: The antifungal activity of PAB against planktonic isolates was evaluated alone and in combination with FLC using the chequerboard microdilution method and growth curve assay. The anti-biofilm effects were quantified by tetrazolium (XTT) reduction assay, which were further confirmed by scanning electron microscopy (SEM) and fluorescent microscope to observe morphological changes of biofilm treated with PAB and FLC.Results: It was revealed that PAB alone exhibited similar inhibitory activity against FLC-resistant and FLC-susceptible strains with median MIC ranging from 8 to 16 mu g/mL. When administered in combination, synergism was observed in all (13/13) FLC-resistant and (2/9) FLC-susceptible strains with FICI ranging from 0.070 to 0.375. Moreover, the concomitant use of PAB and FLC exhibited a strong dose-dependent synergistic inhibitory effect on the early and mature biofilm, eliminating more than 80% biofilm formation. SEM found that PAB, different from azoles, could significantly inhibit spore germination and destroy the cell integrity causing cell deformation, swelling, collapse and outer membrane perforation.Conclusion: PAB was highly active against FLC-resistant isolates and biofilm of C. tropicalis, particularly when combined with FLC. These findings suggest that PAB may have potential as a novel antifungal agent with different targets from azole drugs.

Biotransformation of pseudolaric acid B by Chaetomium globosum

Separation, Determination and Antifungal Activity Test of the Products from A New Bacillus Amyloliquefaciens

Isolation, Purification and Structure Determination of a Novel Antifungal Compound

Biotransformation of Gambogenic Acid by Chaetomium Globosum CICC 2445.

Expanding the Metabolic Profile of the Fungus Chaetomium Sp. Through Co‐culture with Autoclaved Pseudomonas Aeruginosa

The Betulinic Acid Production from Betulin Through Biotransformation by Fungi

Evaluation of Antifungal Metabolites Produced by Lactic Acid Bacteria

Synergistic Effect Of Pseudolaric Acid B With Fluconazole Against Resistant Isolates And Biofilm Of Candida Tropicalis

Biotransformation of Betulonic Acid by the Fungus Rhizopus arrhizus CGMCC 3.868 and Antineuroinflammatory Activity of the Biotransformation Products

Biotransformation of α-asarone by Alternaria longipes CGMCC 3.2875

Secondary Metabolites Produced by Combined Culture of Penicillium crustosum and a Xylaria sp.

Fusaric acid detoxification: a strategy of Gliocladium roseum involved in its antagonism against Fusarium verticillioides

Microbial Transformation of Ursolic Acid by Syncephalastrum Racemosum (cohn) Schroter AS 3.264.

Two new compounds from biotransformation of glycyrrhetinic acid

Biotransformation of (-)-α-pinene and geraniol to α-terpineol and p-menthane-3,8-diol by the white rot fungus, Polyporus brumalis

Mono-/Bis-Alkenoic Acid Derivatives From an Endophytic Fungus Scopulariopsis candelabrum and Their Antifungal Activity

Discovery of a Biocontrol Strain Trichaptum laricinum: Its Metabolites and Antifungal Activity against Pathogenic Fungus Colletotrichum anthrisci

Pseudolaric Acid A: A Promising Antifungal Agent Against Prevalent Non- albicans Candida Species

Drimane Sesquiterpene Alcohols with Activity against Candida Yeast Obtained by Biotransformation with Cladosporium antarcticum

Biotransformation of 20(R)-Panaxadiol by the Fungus Rhizopus Chinensis.

Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal components